title: [Science in a crisis. Medical countermeasures in Ebola virus disease, 2016: lessons learned and perspectives].
abstract: In 2013, the world began to witness an unprecedented Ebola epidemic in West Africa that was smoldering by early 2016. Under this urgent circumstance, the global scientific community organized and made progress in identifying potential preventive countermeasures and therapeutics and accelerated the development of those promising interventions. Trials of experimental interventions soon emerged as a key component of the global response. Hence, an interdisciplinary issue ensued concerning how best to assess clinical safety and effectiveness of potential interventions prior to or concurrent with their broad use in humans. Key issues rely on the close collaboration between research and clinical teams involved in care in the field. Indeed, it is of prime importance to consider cultural dimensions when aiming to build trust within communities and flexibility to adapt trial procedures to field constraints. Trials implemented during the outbreak crisis illustrates challenging inputs for producing scientific and ethical gains for the benefits of vulnerable populations in the context of an international emerging or re-emerging infectious disease event. This includes rapid implementation of clinical research studies from the early phase of the next global outbreak on the basis of practical and ready-to-apply innovative methodological framework built during interepidemic periods.
authors.affiliation: Secteur de médecine tropicale et santé internationale clinique, Service des maladies infectieuses et tropicales, CHU Pellegrin de Bordeaux, place Amélie-Raba-Léon, 33075, Bordeaux, France. denis.malvy@chu-bordeaux.fr.|Inserm U 1219, université de Bordeaux, 33076, Bordeaux, France. denis.malvy@chu-bordeaux.fr.
authors.forename: D
authors.initials: D
authors.lastname: Malvy
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods / Q000458:organization & administration / Q000592:standards; D021821:Communicable Diseases, Emerging / Q000628:therapy; D004196:Disease Outbreaks; D055808:Drug Discovery / Q000379:methods / Q000458:organization & administration / Q000592:standards; D004630:Emergencies / Q000453:epidemiology; D006284:Health Plan Implementation / Q000379:methods / Q000458:organization & administration / Q000592:standards; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D010348:Patient Care Team / Q000458:organization & administration; D035703:Therapies, Investigational / Q000379:methods
keywords: Ebola; Hemorrhagic fever; Therapeutic strategies